What can we learn from animal models of convulsive status epilepticus

作者: S. Bauer , B.A. Norwood

DOI: 10.1007/S10309-012-0278-Y

关键词:

摘要: Animal models of convulsive status epilepticus (SE) are essential tools for studying human SE and developing novel therapies. Although they do not exhibit the prolonged“silent period” that is characteristic typical mesial temporal lobe epilepsy (mTLE) patient, have proven invaluable investigating pathophysiology seizure-induced brain damage. Recurrent spontaneous seizures also make them useful antiepileptic drug screening, albeit only a subset patients who experience frequent, seizures. Chemoconvulsant-based particularly relevant to those survived prolonged severe damage with no apparent latent period. promising results been obtained from animal models, translating into trials has difficult. This may be due several important differences disease, including etiology, neuropathology, seizure manifestation. Provided their limitations acknowledged respected, will continue produce data years come.

参考文章(29)
Braxton A. Norwood, Sebastian Bauer, Sven Wegner, Hajo M. Hamer, Wolfgang H. Oertel, Robert S. Sloviter, Felix Rosenow, Electrical stimulation‐induced seizures in rats: A “dose‐response” study on resultant neurodegeneration Epilepsia. ,vol. 52, ,(2011) , 10.1111/J.1528-1167.2011.03159.X
Martin Holtkamp, Julia Matzen, Katharina Buchheim, Matthew C. Walker, Hartmut Meierkord, Furosemide terminates limbic status epilepticus in freely moving rats. Epilepsia. ,vol. 44, pp. 1141- 1144 ,(2003) , 10.1046/J.1528-1157.2003.14003.X
Jennifer L. Hellier, Peter R. Patrylo, Ping Dou, Michelle Nett, Gregory M. Rose, F. Edward Dudek, Assessment of Inhibition and Epileptiform Activity in the Septal Dentate Gyrus of Freely Behaving Rats During the First Week After Kainate Treatment The Journal of Neuroscience. ,vol. 19, pp. 10053- 10064 ,(1999) , 10.1523/JNEUROSCI.19-22-10053.1999
Ilo E. Leppik, Edward N. Patterson, Lisa D. Coles, Elise M. Craft, James C. Cloyd, Canine Status Epilepticus: A Translational Platform for Human Therapeutic Trials Epilepsia. ,vol. 52, pp. 31- 34 ,(2011) , 10.1111/J.1528-1167.2011.03231.X
D. W. Hochman, S. C. Baraban, J. W. M. Owens, P. A. Schwartzkroin, Dissociation of synchronization and excitability in furosemide blockade of epileptiform activity. Science. ,vol. 270, pp. 99- 102 ,(1995) , 10.1126/SCIENCE.270.5233.99
Harald Prüss, Martin Holtkamp, Ketamine successfully terminates malignant status epilepticus. Epilepsy Research. ,vol. 82, pp. 219- 222 ,(2008) , 10.1016/J.EPLEPSYRES.2008.08.005
Maura Heverin, Tobias Engel, Steve Meaney, Eva M. Jimenez-Mateos, Reza Al-Saudi, David C. Henshall, Bi-lateral changes to hippocampal cholesterol levels during epileptogenesis and in chronic epilepsy following focal-onset status epilepticus in mice Brain Research. ,vol. 1480, pp. 81- 90 ,(2012) , 10.1016/J.BRAINRES.2012.08.018
James WY Chen, Claude G Wasterlain, Status epilepticus: pathophysiology and management in adults Lancet Neurology. ,vol. 5, pp. 246- 256 ,(2006) , 10.1016/S1474-4422(06)70374-X
Argyle V. Bumanglag, Robert S. Sloviter, Minimal latency to hippocampal epileptogenesis and clinical epilepsy after perforant pathway stimulation-induced status epilepticus in awake rats The Journal of Comparative Neurology. ,vol. 510, pp. 561- 580 ,(2008) , 10.1002/CNE.21801